Registration statement for securities of certain foreign private issuers

Interim Condensed Consolidated Statements of Changes in Equity (Unaudited)

v3.19.1
Interim Condensed Consolidated Statements of Changes in Equity (Unaudited) - USD ($)
$ in Thousands
Share capital
Share premium
Capital reserve from share-based payment transactions
Warrants exercisable into shares
Treasury shares
Accumulated other comprehensive income (loss)
Accumulated deficit
Total
Non-controlling interests
Total
Balance at Dec. 31, 2014 $ 1,373 $ 72,534 $ 4,317 $ 2,633 $ (970) $ 389 $ (72,723) $ 7,553 $ 419 $ 7,972
Net loss             (6,243) (6,243) (266) (6,509)
Remeasurement gain (loss) from defined benefit plans           (99)   (99)   (99)
Adjustment arising from translating financial statements from functional currency to presentation currency           (58)   (58)   (58)
Total comprehensive loss           (157) (6,243) (6,400) (266) (6,666)
Issuance of share capital and warrants, net of issue expenses 407 7,330 460 4,314       12,511   12,511
Share-based payments     87         87 22 109
Balance at Dec. 31, 2015 1,780 79,864 4,864 6,947 (970) 232 (78,966) 13,751 175 13,926
Net loss             (8,257) (8,257) (136) (8,393)
Remeasurement gain (loss) from defined benefit plans           140 (140)      
Adjustment arising from translating financial statements from functional currency to presentation currency           119   119   119
Total comprehensive loss           259 (8,397) (8,138) (136) (8,274)
Share-based payments 3   303 306 3 309
Balance at Dec. 31, 2016 1,783 79,864 5,167 6,947 (970) 491 (87,363) 5,919 42 5,961
Net loss             (3,462) (3,462) (53) (3,515)
Adjustment arising from translating financial statements from functional currency to presentation currency           420   420   420
Total comprehensive loss                   (3,095)
Issuance of share capital and warrants, net of issue expenses 330 1,993 188 1,868       4,379   4,379
Share-based payments     95         95   95
Balance at Jun. 30, 2017 2,113 81,857 5,450 8,815 (970) 911 (90,825) 7,351 (11) 7,340
Balance at Dec. 31, 2016 1,783 79,864 5,167 6,947 (970) 491 (87,363) 5,919 42 5,961
Net loss             (6,339) (6,339) (94) (6,433)
Adjustment arising from translating financial statements from functional currency to presentation currency   636 636 636
Total comprehensive loss           636 (6,339) (5,703) (94) (5,797)
Issuance of share capital and warrants, net of issue expenses 330 1,993 188 1,868   4,379 4,379
Issuance of share capital 10 85   95 95
Proceeds from sale of subsidiary in previously consolidated subsidiaries (838) 970   132 52 184
Share-based payments   192   192 192
Balance at Dec. 31, 2017 2,123 81,104 5,547 8,815 1,127 (93,702) 5,014 5,014
Net loss             (2,965) (2,965)   (2,965)
Cumulative effect as a result of the initial adoption of IFRS 15 as of January 1, 2018 - See Note 2             (350) (350)   (350)
Total comprehensive loss                   (2,965)
Issuance of share capital and warrants, net of issue expenses 482 312   3,593       4,387   4,387
Issuance of share capital 28 230           258   258
Share-based payments     166         166   166
Balance at Jun. 30, 2018 2,633 81,646 5,713 12,408 1,127 (97,017) 6,510 6,510
Balance at Dec. 31, 2017 $ 2,123 $ 81,104 $ 5,547 $ 8,815 $ 1,127 $ (93,702) $ 5,014 5,014
Net loss                   (3,142)
Total comprehensive loss                   (3,142)
Balance at Sep. 30, 2018                   $ 6,387